Abbott to pay damages to J&J after federal court ruling
스크롤 이동 상태바
Abbott to pay damages to J&J after federal court ruling
기자명
메디칼라이터팀
입력 2009.07.01 00:00
수정 2009.07.01 01:16
댓글 0
A federal jury in Texas ordered Abbott Laboratories to pay $1.6 billion for infringing on the patent of Johnson & Johnson"s arthritis treatment Remicade [infliximab]. J&J had claimed that Abbott"s Humira [adalimumab] infringed a patent that J&J"s Centocor Ortho Biotech unit held for rival treatment Remicade while Abbott claimed that the patent doesn"t cover the human antibodies used in Humira.